Daratumumab Antibody
Daratumumab is a human IgG1κ monoclonal antibody that specifically binds to the CD38 glycoprotein, which is highly expressed on malignant plasma cells in multiple myeloma. It is widely used in both in vitro and in vivo research to study mechanisms of antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC) against myeloma cells.
Product Specifications
Product Name Alternative
Cytotoxicity, Daratumumab, cell, adhesion, ADC Antibody, ADCAntibody, antibody, Anti-Human CD38, Human Antibody, FcR, Inhibitor, inhibit, myeloma, tumor
Target
CD38, ADC Antibody
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
22 mg/mL
Purity
98.50% (May vary between batches)
Molecular Weight
145.26 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
